Zosano Pharma (NASDAQ:ZSAN) will announce its earnings results on Tuesday, February 27th. Analysts expect the company to announce earnings of ($0.24) per share for the quarter.
Shares of Zosano Pharma (NASDAQ ZSAN) opened at $4.30 on Tuesday. Zosano Pharma has a 12-month low of $3.61 and a 12-month high of $67.60. The stock has a market cap of $8.47, a P/E ratio of -0.18 and a beta of 1.90.
In related news, Director Kenneth Greathouse purchased 55,000 shares of Zosano Pharma stock in a transaction dated Wednesday, December 6th. The stock was bought at an average cost of $0.61 per share, for a total transaction of $33,550.00. Following the transaction, the director now owns 200,000 shares in the company, valued at $122,000. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.83% of the stock is currently owned by company insiders.
A hedge fund recently raised its stake in Zosano Pharma stock. Northern Trust Corp grew its stake in shares of Zosano Pharma Corp (NASDAQ:ZSAN) by 591.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 79,234 shares of the biotechnology company’s stock after acquiring an additional 67,774 shares during the period. Northern Trust Corp owned about 0.20% of Zosano Pharma worth $112,000 at the end of the most recent reporting period.
Separately, ValuEngine upgraded shares of Zosano Pharma from a “strong sell” rating to a “sell” rating in a research report on Sunday, December 31st.
TRADEMARK VIOLATION WARNING: “Zosano Pharma (ZSAN) Scheduled to Post Quarterly Earnings on Tuesday” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/20/zosano-pharma-zsan-scheduled-to-post-quarterly-earnings-on-tuesday.html.
Zosano Pharma Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma and related companies with MarketBeat.com's FREE daily email newsletter.